Stocks rebounded in typical fashion Wednesday, with most sectors participating equally. Trading levels picked up as these days are becoming very obvious to the masses. The smart money is looking for the bounce that fails – signifying a change in market behavior. Recent bounces haven’t lead to much – with only modest gains being achieved all year. Leading stocks moved […]
An FDA advisory panel voted in favor of approving Regeneron (REGN – Analyst Report) and partner Sanofi’s PCSK9 inhibitor, Praluent. A few deals were also signed over the last few days by companies like Vertex (VRTX – Analyst Report), Celgene (CELG – Analyst Report) and Seattle Genetics (SGEN – Analyst Report).Recap of the Week’s Most Important Stories1. Regeneron and Sanofi […]
In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to be under distribution. At the time the IBB traded at approximately $340. My argument rested on negative divergences in the Shares Outstanding / Price action of the IBB, Block Money Flow trends, an increase in volatility, […]
For the top stories on metals and other news, click or MARKET NEWS * Wall Street shares fell on Monday, dragged lower by biotech and healthcare stocks, while European shares and the euro advanced on optimism over talks between Greece and its lenders after There are many different types of window graphic options offered by Markit Media, these include rear […]
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]
Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]
Stocks were generally lower on the day, Monday, lead by large cap names. Trading levels were light, and there were pockets of strength in growth areas. I found quite a few biotech names that looked strong, even though the IBB was negative on the day. The index, along with small cap indexes does not look as broken as the large […]
Originally posted here:
Investing Beyond The Trends: Smart Ways To Play Biotech, Broadband And Housing
See which stocks are being affected by Social Media
[…]
Europe slips lower, Deutsche Bank surges up to 5% – CNBCThe bank said it will appoint John Cryan to become co-chief executive effective July 1, 2015 to replace Anshu Jain who steps down on June 30, 2015.Read MoreDeutsche Bank: Why the dual-CEO system failedThe lender also said co-CEO Juergen Fitschen to remain in his current role until conclusion of annual […]
Read the article –
6.7.15 Week Ahead
See which stocks are being affected by Social Media
[…]
